Ledger.Open graph →
SEC Form D · filed June 15, 2020

Arch Therapeutics, Inc

Offering
$2.0M
Sold
$550K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
FRAMINGHAM, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

James R. Sulat · Framingham, MADirectorRichard E. Davis · Framingham, MAExecTerrence W. Norchi · Framingham, MAExec · DirectorPunit W. Dhillon · Framingham, MADirectorAndrew Goldberger · Tiburon, CADirectorEvan C. Weinstein · New York, NYExecThomas Chen · Inglewood, CAExec · DirectorPhilip C. Crane · Brooklyn, NYDirectorPhillip B. Stern · Wilmington, DEExec · DirectorAhmed El Sarhan · George Town, Grand Cayman, Cayman IslandsExecMonika Mantilla · Coral Gables, FLDirectorStephen Carnes · Winter Park, FLDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗